semaglutide patent canada The story: highlighting the need to maintain protection in Semaglutide patent expiry opens door

Laboratory models of TNBC that were treated with both radiation and a GLP-1 experienced significantly delayed tumor growth and improved overall survival compared to those treated with radiation alone

Bahadorani S, Cho J, Lo T, Contreras H, Lawal HO, Krantz DE, et al

Taube JM, Begum S, Shi C, Eshleman JR, Westra WH

The Triple Receptor Mechanism GLP-1 activation helps reduce appetite and slows stomach emptying

Patients treated are those with type 2 diabetes

A better approach is to address the ED specifically, through hormone testing, nutritional optimization, PDE-5 inhibitors, or other targeted interventions, while continuing the medication that is improving your overall metabolic health